↓ Skip to main content

Dove Medical Press

Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
1 patent

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
35 Mendeley
Title
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
Published in
Therapeutics and Clinical Risk Management, August 2011
DOI 10.2147/tcrm.s12703
Pubmed ID
Authors

Johannes Häberle

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Other 8 23%
Student > Bachelor 5 14%
Researcher 5 14%
Student > Ph. D. Student 4 11%
Student > Doctoral Student 2 6%
Other 4 11%
Unknown 7 20%
Readers by discipline Count As %
Medicine and Dentistry 13 37%
Biochemistry, Genetics and Molecular Biology 5 14%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Psychology 2 6%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2020.
All research outputs
#8,533,995
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#46,666
of 130,319 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#7
of 11 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 130,319 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.